相关实验视频
Updated: Jul 14, 2026

04:28
Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
癌症生物标志物 - 邀请到桌面上的邀请
William S Dalton1, Stephen H Friend
1H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL 33613, USA. dalton@moffitt.usf.edu
概括
基因组技术为个性化医学提供了有前途的癌症生物标志物. 然而,成功实施需要在技术挑战之外解决监管和文化挑战,以充分发挥其潜力.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物标志物研究 生物标志物研究
背景情况:
- 基因组技术正在产生新的生物标志物,用于预测个体癌症患者对治疗的反应.
- 这些生物标志物的有效临床整合需要改变监管批准和患者反应跟踪.
研究的目的:
- 概述癌症生物标志物的识别和验证.
- 讨论生物标志物研究中的技术挑战.
- 突出在患者护理中实施生物标志物的政治和文化障碍.
主要方法:
- 审查正在进行的癌症生物标志物识别和验证工作.
- 讨论技术上的障碍.
- 分析影响生物标志物研究的政治和文化因素.
主要成果:
- 基因组技术对开发预测性癌症生物标志物具有重大前景.
- 技术进步正在进行中,但面临着障碍.
- 政治和文化问题对生物标志物实施构成重大风险.
结论:
- 癌症生物标志物的成功临床应用不仅需要技术进步.
- 解决监管框架和文化接受对于实现生物标志物研究的好处至关重要.
- 积极应对政治和文化挑战对于防止生物标志物驱动的个性化癌症护理脱轨至关重要.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

